Skip to main content
Download PDF
  • Original Paper
  • Published:

Subepithelial trypsin induces enteric nerve-mediated anion secretion by activating proteinase-activated receptor 1 in the mouse cecum

The Journal of Physiological Sciences volume 62, pages 211–219 (2012)Cite this article

Abstract

Serine proteases are versatile signaling molecules and often exert this function by activating the proteinase-activated receptors (PAR1–PAR4). Our previous study on the mouse cecum has shown that the PAR1-activating peptide (AP) and PAR2-AP both induced electrogenic anion secretion. This secretion mediated by PAR1 probably occurred by activating the receptor on the submucosal secretomotor neurons, while PAR2-mediated anion secretion probably occurred by activating the receptor on the epithelial cells. This present study was aimed at using trypsin to further elucidate the roles of serine proteases and PARs in regulating intestinal anion secretion. A mucosal–submucosal sheet of the mouse cecum was mounted in Ussing chambers, and the short-circuit current (I sc) was measured. Trypsin added to the serosal side increased I sc with an ED50 value of approximately 100 nM. This I sc increase was suppressed by removing Cl− from the bathing solution. The I sc increase induced by 100 nM trypsin was substantially suppressed by tetrodotoxin, and partially inhibited by an NK1 receptor antagonist, by a muscarinic Ach-receptor antagonist, and by 5-hydroxytryptamine-3 (5-HT3) and 5-HT4 receptor antagonists. The I sc increase induced by trypsin was partially suppressed when the tissue had been pretreated with PAR1-AP, but not by a pretreatment with PAR2-AP. These results suggest that the serine protease, trypsin, induced anion secretion by activating the enteric secretomotor nerves. This response was initiated in part by activating PAR1 on the enteric nerves. Serine proteases and PARs are likely to be responsible for the diarrhea occurring under intestinal inflammatory conditions.

Introduction

Intestinal fluid secretion is mainly derived from electrogenic anion secretion with its accompanying obligate of Na+ and water. It is important to the physiology of digestion and absorption of nutrients and also for surface lubrication to enable the luminal contents to pass through smoothly. It is also believed to play a role in pathological conditions by flushing out noxious luminal agents [1]. Intestinal anion secretion is controlled by a variety of luminal and subepithelial substances (or by conditions such as mechanical distortion) that may have originated exogenously or be derived from the host itself. They may directly affect the epithelium, but their effects may also be mediated by various neurocrine, paracrine, and endocrine systems. The enteric nervous system, particularly the submucosal nerves, plays a vital role in the neurocrine regulation of intestinal anion secretion [1–3].

Proteases are not merely protein-degrading enzymes, but are now viewed as important signaling molecules that have fundamental roles in a wide variety of physiological processes, and are also associated with multiple disease conditions, including inflammation and cancer [4–9]. Nearly one-third of mammarian proteases are serine proteases, a class that includes trypsin, thrombin, kallikrein, and also type II transmembrane serine protease [8, 9]. Several previous studies have demonstrated in vitro in an Ussing chamber that trypsin and thrombin induced intestinal electrogenic anion secretion [10–14].

The signaling functions of serine proteases are often mediated by the proteinase-activated receptors (PAR1–PAR4). The PAR family members, particularly PAR1 and PAR2, are expressed throughout the gastrointestinal tract on epithelial cells, smooth muscle cells, and enteric nerves [15–17]. The role of PAR1 and PAR2 in regulating intestinal anion secretion has been demonstrated in several isolated intestinal mucosa by using the PAR1-activating peptide (AP) and PAR2-AP [10–13, 18, 19]. In addition, the activation of PAR2 has been implicated in trypsin-induced anion secretion in the mouse distal colon, rat jejunum, and human colon [10, 12, 13]. However, the precise role of PARs in the serine protease-mediated regulation of intestinal transport had remained obscure and was thus investigated in the present study.

The cecum is the largest segment of the large intestine in rodents and many other mammals, and is highly active in luminal fermentation by bacteria as well as in epithelial transport [20, 21]. We have recently reported that both PAR1- and PAR2-APs added to the serosal side induced anion secretion in the mouse cecum in vitro in an Ussing chamber, whereby PAR1-AP-mediated anion secretion occurred by activating submucosal secretomotor neurons, whereas PAR2-AP-mediated anion secretion was by the direct activation of epithelial cells. The activation of anion secretion that was not mediated by the enteric nerve has been demonstrated in the same tissue by applying 10 μM trypsin to the serosal side [14]. Based on these findings, the present study was designed to further elucidate the mechanism for serosal trypsin to regulate intestinal anion secretion in the mouse cecum, and particularly the involvement of PAR1, PAR2, and the enteric nerves. The results suggest that, in contrast to 10 μM trypsin just mentioned, a moderate concentration of trypsin (100 nM) added to the serosal side induced anion secretion by stimulating the submucosal secretomotor nerve, this effect being at least partially due to the activation PAR1, but not PAR2. We also investigated the role of such neurocrine and paracrine mediators as Ach, 5-hydroxytryptamine (5-HT), substance P, and arachidonate metabolites in the 100 nM trypsin-induced anion secretion.

Materials and methods

Tissue preparation

All procedures used in this study were performed in accordance with the “Guiding Principles for Care and Use of Animals” approved by the Physiological Society of Japan and by the Institutional Animal Care Board at the University of Shizuoka. Male mice (30–40 g, Std:ddY; Japan SLC, Hamamatsu, Japan) were fed with standard food and water ad libitum until the time of the experiments. The animals were then killed by cervical dislocation and the cecum was excised. The resulting tissue was opened into a flat sheet, and the musculature was removed by blunt dissection to obtain the mucosa–submucosa preparation. The tissue was divided into four pieces of approximately equal size. One of these pieces was used in most experiments for determining the trypsin-induced response under control conditions, while the others were used for determining the trypsin-induced response under various treatment conditions.

Each piece was then mounted vertically between Ussing-type chambers that provided an exposed area of 0.2 cm2. The volume of the bathing solution on each side was 5 ml, and the solution temperature was maintained at 37°C in a water-jacketed reservoir. The bathing solution contained (mM) NaCl, 119; NaHCO3, 21; K2HPO4, 2.4; KH2PO4, 0.6; CaCl2, 1.2; MgCl2, 1.2; and glucose, 10 (pH 7.4). A Cl-free solution was provided by, respectively, using 119 mM Na-gluconate, 1.2 mM Mg-(gluconate)2 and 8 mM Ca-(gluconate)2 in place of 119 mM NaCl, 1.2 mM MgCl2, and 1.2 mM CaCl2. Each solution was bubbled with 95%O2/5%CO2.

Electrical measurements

The experiments were performed under short-circuit conditions. The short-circuit current (I sc) and transmucosal conductance (G t) were measured by using an automatic voltage-clamping device that compensated for the solution resistance between the potential-measuring electrodes (CEZ9100; Nihon Kohden, Tokyo, Japan) as previously described [22].

Chemicals

Bumetanide, procaine, 3-tropanyl-3,5-dichlorobenzoate, SB-204070 hydrochloride, atropine, hexamethonium, indomethacin, nordihydroguaiaretic acid (NDGA), thrombin from bovine plasma, trypsin from porcine pancreas, soybean trypsin inhibitor, and a P8340 protease inhibitor cocktail in DMSO were purchased from Sigma (St. Louis, MO, USA). Tetrodotoxin (TTX) was purchased from Calbiochem (La Jolla, CA, USA), and L-703,606 and 5-nitro-2-(3-phenylpropylamino)benzoic acid (NPPB) were purchased from Research Biochemical International (Natick, MA, USA). SKF-525A was purchased from Biomol Research Laboratories (Plymouth Meeting, PA, USA). Mouse PAR1 activating peptide (AP) SFFLRN-NH2 and mouse PAR2 AP SLIGRL-NH2 were purchased, respectively, from Yanaihara Institute (Fujinomiya, Japan) and Bachem (Bubendaf, Switzerland). Indomethacin was dissolved in 21 mM NaHCO3. Bumetanide, 3-tropanyl-3,5-dichlorobenzoate, NDGA, and SKF-525A were dissolved in dimethyl sulfoxide, before being administered to the bathing solution, the final concentration of dimethyl sulfoxide being 0.1%. The other chemicals were each applied from an aqueous stock solution.

Data and statistical analysis

Results are expressed as a percentage of the control response determined for each animal. Each value is presented as the mean ± SE, with n representing the number of animals. Statistical comparisons were made by Student’s paired t test, significance being accepted at P < 0.05.

Results

Electrical responses to serosal trypsin

The mucosa–submucosa preparation of the mouse cecum in the Ussing chamber exhibited a basal short-circuit current (I sc) value of 92 ± 6 μA cm−2 and a transmural conductance (G t) value of 20.8 ± 0.4 mS cm−2 (n = 78) 20–30 min after starting the incubation. The I sc value, but not G t, decreased thereafter at the rate of approximately 10% per 10 min.

The addition of trypsin to the serosal solution caused changes in the I sc and G t values (Fig. 1a). I sc was increased rapidly, reaching its peak about 5 min after adding a low concentration of trypsin (10–100 nM), and even more rapidly as the concentration was further increased. The peak increase in I sc was followed by a decrease which, at concentrations of trypsin of more than 1 μM, reached the nearly basal level within 5–20 min. G t increased essentially in parallel with I sc after adding trypsin. It was noted, however, that 10–100 μM serosal trypsin evoked a late decrease in G t to a level below the baseline. We have not explored this effect, but increases in the electrical resistance (=a decrease in G t) and barrier property through the tight junction by extracellular serine protease have been reported in intestinal and other epithelial tissues [23–26]. In addition, 10–100 μM of serosal trypsin subsequently caused a marked and continuing increase in G t in some, but not all preparations, which may reflect possible morphological disorganization by strong proteolysis. Figure 1b shows the relationships between the concentration of serosal trypsin and the resulting I sc and G t changes (only the initial peak increases). The ED50 value was 50–100 nM for both the I sc and G t increases. We mainly explored in this study the response to 100 nM serosal trypsin.

Fig. 1
figure 1

Changes to I sc and G t induced by serosal trypsin. a Time-course characteristics for the changes in I sc and G t induced by 1 nM–100 μM trypsin added to the serosal side at the arrowed time (n = 4–8). Mean values are presented. b Concentration dependence of the serosal trypsin-induced increase in I sc (ΔI sc) and G t (ΔG t). Values were obtained when the peak I sc increases were reached. Each data value is presented the mean ± SE, the number of animals used being 4–8

Full size image

Ionic basis for the serosal trypsin-induced I sc increase

We first examined the ionic basis for the I sc increase induced by trypsin (Fig. 2). The increase in I sc induced by 100 nM serosal trypsin was partially suppressed by 100 μM serosal bumetanide. In addition, Cl− removal from both the mucosal and serosal bathing solutions almost abolished the trypsin-induced I sc increase. Furthermore, mucosal NPPB, a Cl− channel and/or transporter inhibitor (100 μM), largely suppressed the trypsin-induced I sc increase. The trypsin-induced increase in G t was substantially suppressed by Cl− removal and NPPB (Fig. 3). Consequently, the increases in I sc and G t induced by 100 nM trypsin added to the serosal side were probably due to the activation of electrogenic anion secretion [1].

Fig. 2
figure 2

Ionic basis for the increase in I sc induced by 100 nM serosal trypsin. Bumetanide (100 μM, serosal) and 5-nitro-2-(3-phenylpropylamino)benzoic acid (NPPB; 100 μM, mucosal) were added, or Cl − was removed (from both the mucosal and serosal bathing solutions) 20 min before adding 100 nM trypsin to the serosal side. Peak values for the increases in I sc (ΔI sc) induced by trypsin were determined and are expressed as a percentage of the control response obtained in the adjacent tissue. Each data value is presented as the mean ± SE, with n = 4 for bumetanide and n = 5 for the other compounds. *0.01 < P < 0.05 and ***P < 0.001, compared with the control response that had been determined in adjacent tissue by a paired t test

Full size image
Fig. 3
figure 3

Changes in G t (ΔG t) induced by 100 nM serosal trypsin in the presence of various inhibitors. The values were obtained when the peak I sc increases were reached. Each data value is presented as the mean ± SE, with n = 3–6. *0.01 < P < 0.05, **0.001 < P < 0.01, and ***P < 0.001, compared with the control response that had been determined in the adjacent tissue by a paired t test

Full size image

Involvement of the enteric nerves and other mediators

We next explored the role of the enteric nervous system in the anion secretion induced by trypsin. The I sc and G t increases induced by serosal 100 nM trypsin were substantially suppressed by pretreating the tissue with serosal TTX, indicating that they were mediated by the enteric submucosal nerves (Fig. 4; see also Fig. 3). The dependence on submucosal neurons of the I sc and G t increases induced by 100 nM serosal trypsin was supported by the finding that these increases were substantially suppressed by serosal but not by mucosal procaine, a local anesthetic (Fig. 4; see also Fig. 3).

Fig. 4
figure 4

Role of enteric submucosal neurons in serosal 100 nM trypsin-induced Cl− secretion. Tetrodotoxin (TTX, 300 nM), 3-tropanyl-3,5-dichlorobenzoate (20 μM), SB-204070 (10 μM), atropine (10 μM), hexamethonium (10 μM), L-703,606 (10 μM) and pyrilamine (10 μM) were each added to the serosal side, and procaine (50 μM) was added either to the mucosal or serosal side 20 min before adding trypsin (100 nM) to the serosal side. The peak values for the increases in I sc (ΔI sc) induced by trypsin were determined, and are expressed as a percentage of the control response obtained in the adjacent tissue. Each data value is presented as the mean ± SE, with n = 3 for 3-tropanyl-3,5-dichlorobenzoate + SB-204070 (10 μM), n = 6 for mucosal procaine and pyrilamine, and n = 5 for the other compounds. *0.01 < P < 0.05, **0.001 < P < 0.01, and ***P < 0.001, compared with the control response by a paired t test

Full size image

We then elucidated the involvement of 5-HT by examining the effects of the 5-HT3-receptor antagonist, 3-tropanyl-3,5-dichlorobenzoate, and of the 5-HT4-receptor antagonist, SB-204070. The I sc and G t increases induced by 100 nM serosal trypsin was significantly suppressed when the tissues had been pretreated with both the 5-HT3 and 5HT4 receptor antagonists (Fig. 4; see also Fig. 3).

We then examined the role of neurotransmitters Ach and tachykinin in the 100 nM serosal trypsin-induced anion secretion by using antagonists for the musocarinic and nicotinic acetylcholine receptors (atropine and hexamethonium) and that for the tachykinin NK1 receptor (L-703,606). Atropine significantly reduced the increase in I sc, but not G t, induced by 100 nM serosal trypsin, while hexamethonium had a minor influence on the response (Fig. 4; also see Fig. 3). In contrast, the trypsin-induced increases in I sc and G t were both considerably decreased by L-703,606 (Fig. 4; also see Fig. 3). These results suggest that trypsin stimulated the release of substance P, resulting in activation of the NK1 receptor, and some Ach release to activate the muscarinic receptor.

The H1 histamine receptor antagonist, pyrilamine, slightly but insignificantly suppressed the trypsin-induced increase in I sc (Fig. 4, ; also see Fig. 3)

Involvement of eicosanoids

We next explored the role of arachidonate metabolites (collectively called eicosanoids) in the serosal 100 nM trypsin-induced anion secretion by examining the effects of pretreating the tissue with indomethacin, an inhibitor of cyclooxygenase, nordihydroguaiaretic acid (NDGA), an inhibitor of lipoxygenases, and SKF-525A, an inhibitor of cytochrome P450 monooxygenases, on the trypsin-induced anion secretion (Fig. 5; also see Fig. 3). The I sc increase induced by trypsin was not significantly affected by indomethacin (10 μM, both mucosal and serosal sides), but was significantly inhibited by NDGA (50 μM, serosal side) and SKF-525A (30 μM, serosal side). These results suggest that arachidonate metabolites of the lipoxygenase and cytochrome P450 monooxygenase pathways are involved in the trypsin-induced response.

Fig. 5
figure 5

Effect of inhibitors of arachidonic acid metabolism on I sc induced by 100 nM serosal trypsin. Indomethacin (10 μM) was added to both the mucosal and serosal sides, and NDGA (50 μM) and SKF-525A (30 μM) were each added to the serosal side 20 min before adding trypsin (100 nM) to the serosal side. Each data value is presented as the mean ± SE, with n = 5. ***P < 0.001, compared with the control response that had been determined in the adjacent tissue by a paired t test

Full size image

Role of the proteinase-activated receptors

The I sc increase induced by 100 nM serosal trypsin was substantially suppressed by the protease inhibitor cocktail (Fig. 6). Furthermore, the presence of a soybean trypsin inhibitor (0.59 mg/ml) on the serosal side almost completely abolished the increase in I sc induced by 100 nM serosal trypsin ( Fig. 7d). The stimulatory effect of 100 nM serosal trypsin on the electrical response therefore required the proteolytic activity of trypsin.

Fig. 6
figure 6

Effect of the protease inhibitor cocktail (P8340; Sigma) on the I sc increase induced by trypsin. The protease inhibitor cocktail was added to the serosal solution (diluted 1,000-fold) 20 min before adding 100 nM trypsin to the serosal solution. Peak values for the increases in I sc (ΔI sc) induced by trypsin were determined and are expressed as a percentage of the control response obtained in the adjacent tissue. Each data value is presented as the mean ± SE, with n = 4. ***P < 0.001, compared with the control response that had been determined in the adjacent tissue by a paired t test

Full size image
Fig. 7
figure 7

Involvement of proteinase-activated receptor type 1 (PAR1) in the serosal trypsin-induced I sc increase. a–c Attenuation of the ΔI sc induced by trypsin after pre-exposure to SFFLRN-NH 2 , a PAR1-activating peptide (AP). a The control ΔI sc induced by serosal trypsin (100 nM). Mean values are presented, n = 4. b ΔI sc induced by trypsin was obtained in the tissue that had been pretreated with serosal SFFLRN-NH2. Mean values are presented, n = 4. c Peak values for ΔI sc induced by serosal trypsin (100 nM) in the absence (control; shown in a) and presence (SFFLRN-NH 2 ; shown in b) of pre-exposure to PAR1-AP. Each data value is presented as the mean ± SE. *P < 0.05, paired t test. d–e Attenuation of ΔI sc induced by the serosal PAR1-AP (30 μM), after pre-exposure to serosal trypsin (100 nM). d The control ΔI sc induced by SFFLRN-NH2 was obtained in tissue that had been pretreated with trypsin, but only after the soybean trypsin inhibitor (0.59 mg/ml, serosal side) had been added. Mean values are presented, n = 4. e The soybean trypsin inhibitor was added after trypsin had worked for 20 min, and ΔI sc induced by SFFLRN-NH2 was finally obtained. Mean values are presented, n = 4. f The peak values for the increases in I sc (ΔI sc) induced by SFFLRN-NH2 after pre-exposure to trypsin (trypsin treated; shown in e) are expressed as a percentage of the control response (control; shown in d) obtained in the adjacent tissue. Each data value is presented as the mean ± SE. *P < 0.05, paired t test

Full size image

We then explored the mediation of PAR1 and/or PAR2 in the action of trypsin, since our previous study has reported that both the PAR1-AP and PAR2-AP, but not PAR4-AP, stimulated anion secretion in the mouse cecum when added to the serosal side [14]. Both PAR1 and PAR2 are known to be activated by trypsin [16, 27]. To this end we determined the change in the trypsin-induced response after PAR1 or PAR2 desensitization. Figure 7a–c show that pretreating the tissue with 30 μM SFFLRN-NH2 (a PAR1-AP) to desensitize PAR1 [14] significantly reduced the I sc increase induced by serosal trypsin, suggesting that activation of PAR1 on the enteric nerve is partially responsible for the trypsin-induced response. In addition, Fig. 7d–f show that the I sc response induced by the PAR1-AP was significantly decreased, but not abolished, when serosal trypsin (100 nM) had operated for 20 min before applying PAR1-AP. Taking these results together, it is likely that serosal trypsin probably activated PAR1 on the submucosal nerves and initiated the secretomotor reflex. On the other hand, pretreating the tissue with SLIGRL-NH2, a PAR2-AP, thereby desensitizing PAR2 [14], did not suppress the I sc increase induced by serosal trypsin, but rather significantly enhanced it (Fig. 8). Although this enhancement is difficult to explain at the moment, PAR2 activation may not have participated in the anion secretion induced by serosal 100 nM trypsin. The results thus suggest that other pathways not involving PAR1 or PAR2 were also involved in the trypsin-induced anion secretion.

Fig. 8
figure 8

Effects of pretreating by SLIGRL-NH 2 , a PAR2-AP, on the trypsin-induced increase in I sc (ΔI sc). a The control ΔI sc value induced by serosal trypsin (100 nM). Mean values are presented, n = 14. b ΔI sc induced by trypsin was obtained for tissue that had been treated with serosal SLGRL-NH2. Mean values are presented, n = 7. c ΔI sc values induced by serosal trypsin are presented in the tissue that had been pre-exposed to SLGRL-NH2 or not. Each data value is presented as the mean ± SE. *P < 0.05, unpaired t test

Full size image

Discussion

Effect of trypsin

The present results for the mouse cecum demonstrate that trypsin added to the serosal side induced electrogenic anion secretion with an ED50 value of 50–100 nM. Previous studies on the mammalian small and large intestines in an Ussing chamber have demonstrated that serosal trypsin could stimulate anion secretion with an ED50 value of 10–100 nM in most cases, this being similar to the value obtained in the present study [10–14]. However, the mechanism for stimulating anion secretion by trypsin appears to be diverse according to the intestinal segment, the dose of trypsin, and probably animal species. For example, the response in the mouse distal colon and porcine ileum was abolished by TTX [11, 12], like the response to 100 nM trypsin in the mouse cecum that was observed in the present study. On the other hand, the anion secretion induced by serosal trypsin has not been inhibited by TTX in the human rectum [13]. In addition, our previous study on the mouse cecum has shown that, in sharp contrast to the moderate concentration used in the present study (100 nM), the activation of anion secretion induced by a high concentration of trypsin (10 μM) was not inhibited by TTX, indicating a dose-dependent difference in the action of trypsin [14]. Trypsin would be likely to induce the inhibition of Na and/or Cl absorption, in addition to the stimulation of anion secretion, since the stimulants of anion secretion in the intestines often simultaneously inhibit NaCl absorption to facilitate a net fluid secretion [1]. However, this likelihood has not yet been addressed.

Role of PARs

PAR1 and PAR2 have previously been demonstrated morphologically and functionally to be expressed in epithelial cells and/or enteric nerves and have been suggested to play a role in regulating intestinal secretion [10–14, 18, 19, 28, 29]. The results of the present study show that the I sc increase induced by trypsin was partially suppressed by pretreating with 30 μM PAR1-AP, which had been shown to almost completely desensitize PAR1 [14]. It is therefore likely that trypsin induced anion secretion at least in part by activating PAR1, probably on the submucosal enteric nerve. Indeed, PAR1-AP has been shown to stimulate enteric nerve-mediated anion secretion [14], and also to be expressed in submucosal nerves [19]. It is intriguing that the role of PAR1 in the enteric nerve appears to be complex, since PAR1-AP has been reported to inhibit the anion secretion evoked by stimulating enteric nerves in the mouse proximal colon, a segment next to the cecum [18].

We have previously shown that PAR2-AP stimulates anion secretion that is not inhibited by TTX. Here, 100 nM serosal trypsin evoked almost no anion secretion when the tissue was treated with TTX (Fig. 4), thus excluding a major role for PAR2 in trypsin-induced anion secretion. In agreement with this notion, desensitizing PAR2 failed to reduce the subsequent response to trypsin (Fig. 8). Other pathways not involving PAR1 or PAR2 would therefore also be involved in the trypsin-induced anion secretion. The failure of 100 nM trypsin to activate PAR2 and induce anion secretion in the mouse cecum was an unexpected finding, since PAR2 was expressed in this preparation and PAR2-AP can evoke anion secretion that is not mediated by enteric nerves [14]. In fact, a high concentration of trypsin (10 μM) can induce TTX-insensitive anion secretion [14]. Possibly, it was difficult, and therefore required a high concentration for large trypsin molecules to gain access to PAR2 residing deep in the tissue, probably on epithelial cells. The involvement of PAR2 in trypsin-induced anion secretion has been shown in the mouse distal colon and rat jejunum [10, 12, 13]. Taking this information together, PARs are likely to be present on various cell types and to play important roles in trypsin or other serine proteases regulating intestinal ion transport, but their precise roles are probably diverse according to the intestinal segment and animal species.

Neurocrine and paracrine mediators

The anion secretion induced by 100 nM serosal trypsin was partially inhibited by the muscarinic receptor antagonist, atropine, suggesting the involvement of Ach release from submucosal cholinergic secretomotor nerves [1–3, 30, 31]. The present results also suggest that activation of the NK1 receptor by substance P, which was probably released from afferent nerves, would also be responsible in part for the anion secretion reflex induced by trypsin [14, 32–37]. NK1 receptors have recently been shown to be abundantly expressed in subepithelial fibroblasts, although the relevance of this intriguing finding to the anion secretion induced by trypsin needs to be more fully investigated [38].

The anion secretion stimulated by 100 nM serosal trypsin was partially inhibited in the presence of both the 5-HT3 receptor and 5-HT4 receptor antagonists, suggesting the involvement of 5-HT release in this response [2, 3, 39–41]. 5-HT is mainly present in the epithelial enterochromaffin cells, but is also contained in the enteric nerve and mucosal mast cells [3, 39–41]. The mechanism by which trypsin stimulates any of these cells to release 5-HT remains for future study.

Arachidonic acid released from membrane phospholipids can be metabolized to generate various eicosanoids via three enzymatic routes: the cyclooxygenase, lipoxygenase and cytochrome P-450 epoxygenase pathways [42, 43]. The trypsin-induced anion secretion in the present study was substantially suppressed by NDGA (a lipoxygenase inhibitor) and SKF-525A (a cytochrome P-450 inhibitor), but not significantly affected by indomethacin (a cyclooxygenase inhibitor). This suggests that metabolites of the lipoxygenase pathway, hydroxyeicosatetraenoic acids (HETEs) and leukotrienes, and those of epoxygenase pathway, HETEs and epoxyeicosatrienoic acids (EETs), were involved in the response, but not that of the metabolites on the cyclooxygenase pathway, prostanoids. The intestinal mucosa has been shown to produce lipoxygenase metabolites [43, 44], which have been found to activate or inhibit anion secretion [45–50]. P450 expoxygenases and the production of HETEs and EETs have also been demonstrated in the intestinal tissues, although their role in regulating anion secretion is not known [42, 43, 51–53]. The cell types involved in releasing the lipoxygenase and epoxygenase metabolites of arachidonic acid in response to trypsin remain to be determined. Although prostanoids have hardly been involved in trypsin-induced anion secretion in the cecum, the anion secretion stimulated by PAR1-AP or PAR2-AP has been shown to be mediated via prostaglandin production in certain intestinal tissues [16, 43, 54–56].

Conclusion

The serine protease, trypsin, can induce anion secretion by activating the enteric secretomotor nerves in the mouse cecum. This response was initiated in part by activating PAR1, probably on the enteric nerves. Other pathways not involving PAR1 or PAR2 would also have been involved, but their precise action remains for future investigation. Since serine proteases are known to be recruited and/or activated under certain pathological conditions, they are likely to play a role in the development of diarrhea that is often observed under such conditions [1, 57–63]. This reaction may be important for protecting the intestine, particularly the cecum, by washing harmful microbes and their toxic products out of the lumen [21]. The natural proteases working in situ and the precise mode of their actions in regulating intestinal fluid secretion may vary under specific conditions and warrant further investigation.

References

  1. Field M (2003) Intestinal ion transport and the pathophysiology of diarrhea. J Clin Invest 111(7):931–943

    PubMed  CAS  Google Scholar 

  2. Cooke HJ, Christofi FL (2006) Enteric neural regulation of mucosal secretion. In: Johnson L (ed) Physiology of the gastrointestinal tract, 4th edn. Academic, London, pp 737–762

    Google Scholar 

  3. Furness JB (2006) The enteric nervous system. Blackwell, Carlton

    Google Scholar 

  4. Puente XS et al (2003) Human and mouse proteases: a comparative genomic approach. Nat Rev Genet 4(7):544–558

    Article  PubMed  CAS  Google Scholar 

  5. Turk B (2006) Targeting proteases: successes, failures and future prospects. Nat Rev Drug Discov 5(9):785–799

    Article  PubMed  CAS  Google Scholar 

  6. Lopez-Otin C, Bond JS (2008) Proteases: multifunctional enzymes in life and disease. J Biol Chem 283(45):30433–30437

    Article  PubMed  CAS  Google Scholar 

  7. Page MJ, Di Cera E (2008) Serine peptidases: classification, structure and function. Cell Mol Life Sci 65(7–8):1220–1236

    Article  PubMed  CAS  Google Scholar 

  8. Antalis TM et al (2010) The cutting edge: membrane-anchored serine protease activities in the pericellular microenvironment. Biochem J 428(3):325–346

    Article  PubMed  CAS  Google Scholar 

  9. Rawlings ND, Barrett AJ, Bateman A (2010) MEROPS: the peptidase database. Nucleic Acids Res 38(Database issue):D227–D233

    Google Scholar 

  10. Vergnolle N et al (1998) Proteinase-activated receptor 2 (PAR2)-activating peptides: identification of a receptor distinct from PAR2 that regulates intestinal transport. Proc Natl Acad Sci USA 95(13):7766–7771

    Article  PubMed  CAS  Google Scholar 

  11. Green BT et al (2000) Intestinal type 2 proteinase-activated receptors: expression in opioid-sensitive secretomotor neural circuits that mediate epithelial ion transport. J Pharmacol Exp Ther 295(1):410–416

    PubMed  CAS  Google Scholar 

  12. Cuffe JE et al (2002) Basolateral PAR-2 receptors mediate KCl secretion and inhibition of Na+ absorption in the mouse distal colon. J Physiol 539(Pt 1):209–222

    Article  PubMed  CAS  Google Scholar 

  13. Mall M et al (2002) Activation of ion secretion via proteinase-activated receptor-2 in human colon. Am J Physiol Gastrointest Liver Physiol 282(2):G200–G210

    PubMed  CAS  Google Scholar 

  14. Ikehara O et al (2010) Proteinase-activated receptors-1 and 2 induce electrogenic Cl– secretion in the mouse cecum by distinct mechanisms. Am J Physiol Gastrointest Liver Physiol 299(1):G115–G125

    Article  PubMed  CAS  Google Scholar 

  15. Ossovskaya VS, Bunnett NW (2004) Protease-activated receptors: contribution to physiology and disease. Physiol Rev 84(2):579–621

    Article  PubMed  CAS  Google Scholar 

  16. Kawabata A, Matsunami M, Sekiguchi F (2008) Gastrointestinal roles for proteinase-activated receptors in health and disease. Br J Pharmacol 153(Suppl 1):S230–S240

    PubMed  CAS  Google Scholar 

  17. Adams MN et al (2011) Structure, function and pathophysiology of protease activated receptors. Pharmacol Ther 130(3):248–282

    Article  PubMed  CAS  Google Scholar 

  18. Buresi MC et al (2005) Activation of proteinase-activated receptor-1 inhibits neurally evoked chloride secretion in the mouse colon in vitro. Am J Physiol Gastrointest Liver Physiol 288(2):G337–G345

    Article  PubMed  CAS  Google Scholar 

  19. Mueller K et al (2011) Activity of protease-activated receptors in the human submucous plexus. Gastroenterology 141(6):2088–2097.e1

    Google Scholar 

  20. Kawamata K, Hayashi H, Suzuki Y (2007) Propionate absorption associated with bicarbonate secretion in vitro in the mouse cecum. Pflugers Arch 454(2):253–262

    Article  PubMed  CAS  Google Scholar 

  21. Bergman EN (1990) Energy contributions of volatile fatty acids from the gastrointestinal tract in various species. Physiol Rev 70(2):567–590

    PubMed  CAS  Google Scholar 

  22. Koyama K et al (1999) Induction of epithelial Na+ channel in rat ileum after proctocolectomy. Am J Physiol 276(4 Pt 1):G975–G984

    PubMed  CAS  Google Scholar 

  23. Lynch RD et al (1995) Basolateral but not apical application of protease results in a rapid rise of transepithelial electrical resistance and formation of aberrant tight junction strands in MDCK cells. Eur J Cell Biol 66(3):257–267

    PubMed  CAS  Google Scholar 

  24. Swystun VA et al (2009) Serine proteases decrease intestinal epithelial ion permeability by activation of protein kinase Czeta. Am J Physiol Gastrointest Liver Physiol 297(1):G60–G70

    Article  PubMed  CAS  Google Scholar 

  25. Buzza MS et al (2010) Membrane-anchored serine protease matriptase regulates epithelial barrier formation and permeability in the intestine. Proc Natl Acad Sci USA 107(9):4200–4205

    Article  PubMed  CAS  Google Scholar 

  26. Steensgaard M et al (2010) Apical serine protease activity is necessary for assembly of a high-resistance renal collecting duct epithelium. Acta Physiol (Oxf) 200(4):347–359

    Article  CAS  Google Scholar 

  27. Kwong K et al (2010) Thrombin and trypsin directly activate vagal C-fibres in mouse lung via protease-activated receptor-1. J Physiol 588(Pt 7):1171–1177

    Article  PubMed  CAS  Google Scholar 

  28. D’Andrea MR et al (1998) Characterization of protease-activated receptor-2 immunoreactivity in normal human tissues. J Histochem Cytochem 46(2):157–164

    Article  PubMed  Google Scholar 

  29. Reed DE et al (2003) Mast cell tryptase and proteinase-activated receptor 2 induce hyperexcitability of guinea-pig submucosal neurons. J Physiol 547(Pt 2):531–542

    Article  PubMed  CAS  Google Scholar 

  30. Sang Q, Young HM (1998) The identification and chemical coding of cholinergic neurons in the small and large intestine of the mouse. Anat Rec 251(2):185–199

    Article  PubMed  CAS  Google Scholar 

  31. Hirota CL, McKay DM (2006) Cholinergic regulation of epithelial ion transport in the mammalian intestine. Br J Pharmacol 149(5):463–479

    Article  PubMed  CAS  Google Scholar 

  32. Kuwahara A, Cooke HJ (1990) Tachykinin-induced anion secretion in guinea pig distal colon: role of neural and inflammatory mediators. J Pharmacol Exp Ther 252(1):1–7

    PubMed  CAS  Google Scholar 

  33. Holzer P, Holzer-Petsche U (2001) Tachykinin receptors in the gut: physiological and pathological implications. Curr Opin Pharmacol 1(6):583–590

    Article  PubMed  CAS  Google Scholar 

  34. Southwell BR, Furness JB (2001) Immunohistochemical demonstration of the NK(1) tachykinin receptor on muscle and epithelia in guinea pig intestine. Gastroenterology 120(5):1140–1151

    Article  PubMed  CAS  Google Scholar 

  35. Hosoda Y et al (2002) Substance P-evoked Cl− secretion in guinea pig distal colonic epithelia: interaction with PGE2. Am J Physiol Gastrointest Liver Physiol 283(2):G347–G356

    PubMed  CAS  Google Scholar 

  36. Shimizu Y et al (2008) Tachykinins and their functions in the gastrointestinal tract. Cell Mol Life Sci 65(2):295–311

    Article  PubMed  CAS  Google Scholar 

  37. Mitsui R (2011) Immunohistochemical analysis of substance P-containing neurons in rat small intestine. Cell Tissue Res 343(2):331–341

    Article  PubMed  CAS  Google Scholar 

  38. Furuya S et al (2010) Localization of NK1 receptors and roles of substance-P in subepithelial fibroblasts of rat intestinal villi. Cell Tissue Res 342(2):243–259

    Article  PubMed  CAS  Google Scholar 

  39. Gershon MD (2004) Review article: serotonin receptors and transporters—roles in normal and abnormal gastrointestinal motility. Aliment Pharmacol Ther 20(Suppl 7):3–14

    Article  PubMed  CAS  Google Scholar 

  40. Gershon MD, Tack J (2007) The serotonin signaling system: from basic understanding to drug development for functional GI disorders. Gastroenterology 132(1):397–414

    Article  PubMed  CAS  Google Scholar 

  41. Hansen MB, Witte AB (2008) The role of serotonin in intestinal luminal sensing and secretion. Acta Physiol (Oxf) 193(4):311–323

    Article  CAS  Google Scholar 

  42. Zeldin DC (2001) Epoxygenase pathways of arachidonic acid metabolism. J Biol Chem 276(39):36059–36062

    Article  PubMed  CAS  Google Scholar 

  43. Ferrer R, Moreno JJ (2010) Role of eicosanoids on intestinal epithelial homeostasis. Biochem Pharmacol 80(4):431–438

    Article  PubMed  CAS  Google Scholar 

  44. Dreyling KW et al (1986) Leukotriene synthesis by human gastrointestinal tissues. Biochim Biophys Acta 878(2):184–193

    PubMed  CAS  Google Scholar 

  45. Musch MW et al (1982) Stimulation of colonic secretion by lipoxygenase metabolites of arachidonic acid. Science 217(4566):1255–1256

    Article  PubMed  CAS  Google Scholar 

  46. Calderaro V et al (1991) Arachidonic acid metabolites and chloride secretion in rabbit distal colonic mucosa. Am J Physiol 261(3 Pt 1):G443–G450

    PubMed  CAS  Google Scholar 

  47. Wegmann M et al (2000) Effect of hydroxyeicosatetraenoic acids on furosemide-sensitive chloride secretion in rat distal colon. J Pharmacol Exp Ther 295(1):133–138

    PubMed  CAS  Google Scholar 

  48. Reims A et al (2005) Cysteinyl leukotrienes are secretagogues in atrophic coeliac and in normal duodenal mucosa of children. Scand J Gastroenterol 40(2):160–168

    Article  PubMed  CAS  Google Scholar 

  49. Mahmood B et al (2006) Colonic secretion studied in vitro in rats fed polyunsaturated fatty acids. Bangladesh Med Res Counc Bull 32(3):72–77

    PubMed  CAS  Google Scholar 

  50. Shimizu T et al (2007) Effects of alpha-linolenic acid on colonic secretion in rats with experimental colitis. J Gastroenterol 42(2):129–134

    Article  PubMed  CAS  Google Scholar 

  51. Macica C et al (1993) Characterization of cytochrome P-450-dependent arachidonic acid metabolism in rabbit intestine. Am J Physiol 265(4 Pt 1):G735–G741

    PubMed  CAS  Google Scholar 

  52. Zeldin DC et al (1997) CYP2J subfamily cytochrome P450s in the gastrointestinal tract: expression, localization, and potential functional significance. Mol Pharmacol 51(6):931–943

    PubMed  CAS  Google Scholar 

  53. Thelen K, Dressman JB (2009) Cytochrome P450-mediated metabolism in the human gut wall. J Pharm Pharmacol 61(5):541–558

    Article  PubMed  CAS  Google Scholar 

  54. Buresi MC et al (2002) Activation of proteinase-activated receptor 1 stimulates epithelial chloride secretion through a unique MAP kinase- and cyclo-oxygenase-dependent pathway. FASEB J 16(12):1515–1525

    Article  PubMed  CAS  Google Scholar 

  55. Kirkland JG et al (2007) Agonists of protease-activated receptors 1 and 2 stimulate electrolyte secretion from mouse gallbladder. Am J Physiol Gastrointest Liver Physiol 293(1):G335–G346

    Article  PubMed  CAS  Google Scholar 

  56. van der Merwe JQ et al (2009) Prostaglandin E2 derived from cyclooxygenases 1 and 2 mediates intestinal epithelial ion transport stimulated by the activation of protease-activated receptor 2. J Pharmacol Exp Ther 329(2):747–752

    Article  PubMed  Google Scholar 

  57. Deitch EA et al (2003) Serine proteases are involved in the pathogenesis of trauma-hemorrhagic shock-induced gut and lung injury. Shock 19(5):452–456

    Article  PubMed  CAS  Google Scholar 

  58. Cenac N et al (2007) Role for protease activity in visceral pain in irritable bowel syndrome. J Clin Invest 117(3):636–647

    Article  PubMed  CAS  Google Scholar 

  59. Roka R et al (2007) A pilot study of fecal serine-protease activity: a pathophysiologic factor in diarrhea-predominant irritable bowel syndrome. Clin Gastroenterol Hepatol 5(5):550–555

    Article  PubMed  CAS  Google Scholar 

  60. Gecse K et al (2008) Increased faecal serine protease activity in diarrhoeic IBS patients: a colonic lumenal factor impairing colonic permeability and sensitivity. Gut 57(5):591–599

    Article  PubMed  CAS  Google Scholar 

  61. Annahazi A et al (2009) Fecal proteases from diarrheic-IBS and ulcerative colitis patients exert opposite effect on visceral sensitivity in mice. Pain 144(1–2):209–217

    Article  PubMed  CAS  Google Scholar 

  62. Buhner S et al (2009) Activation of human enteric neurons by supernatants of colonic biopsy specimens from patients with irritable bowel syndrome. Gastroenterology 137(4):1425–1434

    Article  PubMed  CAS  Google Scholar 

  63. Lee JW et al (2010) Subjects with diarrhea-predominant IBS have increased rectal permeability responsive to tryptase. Dig Dis Sci 55(10):2922–2928

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgment

We thank Tony Innes of Link Associates for helping to edit the English text.

Conflict of interest

No conflicts of interest, financial or otherwise, are declared by the authors.

Author information

Authors and Affiliations

  1. Laboratory of Physiology, School of Food and Nutritional Sciences, University of Shizuoka, Yada 52-1, Surugaku, Shizuoka, 422-8526, Japan

    Osamu Ikehara, Hisayoshi Hayashi, Toshiharu Waguri & Yuichi Suzuki

  2. Laboratory of Physiology, Department of Environmental Health Sciences, Graduate School of Nutritional and Environmental Sciences, University of Shizuoka, Yada 52-1, Surugaku, Shizuoka, 422-8526, Japan

    Izumi Kaji, Shin-ichiro Karaki & Atsukazu Kuwahara

Authors
  1. Osamu Ikehara
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hisayoshi Hayashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Toshiharu Waguri
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Izumi Kaji
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Shin-ichiro Karaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Atsukazu Kuwahara
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Yuichi Suzuki
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yuichi Suzuki.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ikehara, O., Hayashi, H., Waguri, T. et al. Subepithelial trypsin induces enteric nerve-mediated anion secretion by activating proteinase-activated receptor 1 in the mouse cecum. J Physiol Sci 62, 211–219 (2012). https://doi.org/10.1007/s12576-012-0198-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12576-012-0198-7

Keywords

The Journal of Physiological Sciences

ISSN: 1880-6562

Contact us